Neurent Medical
Neurent Medical develops treatments for chronic rhinitis and other nasal conditions that target their root cause.
- Company
- Braintree, MA, USUnited States
Neurent Medical develops treatments for chronic rhinitis and other nasal conditions that target their root cause.
neuromark.comCrawled Oct 27, 2026
The Neuromark System helps ENT practices provide lasting relief from chronic rhinitis.
NEUROMARK treats Chronic Rhinitis at the source by gently disrupting overactive nasal nerves using low-power radiofrequency energy.
Access the official NEUROMARK Instructions for Use (IFU) for detailed guidance on system operation, safety, and mechanism of action.
The page provides safety information for the Neuromark System to ensure optimal patient and provider outcomes.
The page discusses posterior nasal nerve ablation as an in-office treatment option for chronic rhinitis when medical therapy fails.
The page provides clinical studies, physician testimonials, and educational materials supporting Neuromark for chronic rhinitis.
Neurent Medical received FDA 510(k) clearance for its updated Neuromark System, a minimally invasive device for chronic rhinitis treatment.
Neurent Medical announces the commercial availability of NEUROMARK System in limited U.S. markets.
In 2023, the Centers for Medicare and Medicaid Services (CMS) assigned a Category I Current Procedural Terminology (CPT) reimbursement code for a breakthrough minimally invasive procedure for patients suffering from Chronic Rhinitis.
Study demonstrates superiority of radiofrequency posterior nasal nerve ablation versus sham control in patients with chronic rhinitis.
Neurent Medical lists job openings for its team working on chronic rhinitis care and the Neuromark solution.
Neurent Medical lists current openings and says its team is working to bring the NEUROMARK solution to more patients.
Coverage for NEUROMARK includes Medicare/Medicaid and some commercial insurance plans.
MyMark provides reimbursement support including appeals, case updates, and billing assistance.
NEUROMARK offers a gentle, minimally invasive alternative to medication or surgery.
NEUROMARK gently targets nasal nerves to treat Chronic Rhinitis, avoiding meds or invasive surgery.
NEUROMARK offers a gentle, minimally invasive alternative to medication or surgery.
NEUROMARK gently targets nasal nerves to treat Chronic Rhinitis, avoiding meds or invasive surgery.
Neurent Medical develops non-surgical ENT solutions for chronic rhinitis and other inflammatory sinonasal conditions.
Neurent Medical develops non-surgical ENT solutions for chronic rhinitis and other inflammatory sinonasal conditions.
The Neuromark physician locator helps find ENT specialists offering Neuromark for chronic rhinitis.
The page answers questions about Neuromark treatment for chronic rhinitis, including procedure details, safety, recovery, and provider information.
The page provides expert answers about chronic rhinitis and the Neuromark procedure.
Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
The page details Neurent Medical’s privacy policy, explaining data collection, use, and protection.
The page outlines the terms and conditions for using the Neurent Medical website, including legal disclaimers and user responsibilities.
Neurent Medical raises **€25 million in growth debt** from Claret Capital Partners to expand its commercial operations. The company develops the **NEUROMARK® System**, a treatment for **chronic rhinitis**. The funding supports scaling efforts to reach more patients and strengthen market presence.
Sep 2026PR NewswireNews article
Neurent Medical, an Irish medtech company, focuses on addressing chronic rhinitis through innovative medical solutions. The company has achieved a series of milestones in its development, positioning itself as a key player in the ear, nose, and throat (ENT) sector.
Mar 2026MassDeviceNews article
Neurent Medical publishes positive randomized controlled trial results for its **NEUROMARK® System**, a non-surgical treatment for **chronic rhinitis**. The study demonstrates efficacy in addressing symptoms without invasive procedures. The company specializes in developing alternative therapies for nasal and sinus conditions.
Feb 2026PR NewswireNews article
Neurent Medical secures €62.5 million in oversubscribed Series C funding to accelerate commercial expansion of its NEUROMARK® device, a minimally invasive treatment for chronic rhinitis. The financing supports broader market access and adoption of the therapy. NEUROMARK® targets patients with persistent nasal inflammation, offering an alternative to long-term medication use.
Feb 2026PR NewswireNews article